Compare FBRX & KRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBRX | KRSP |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 474.3M |
| IPO Year | 2017 | N/A |
| Metric | FBRX | KRSP |
|---|---|---|
| Price | $27.32 | $10.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 385.9K | 39.0K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.50 | $10.21 |
| 52 Week High | $35.80 | $10.70 |
| Indicator | FBRX | KRSP |
|---|---|---|
| Relative Strength Index (RSI) | 44.26 | 53.64 |
| Support Level | $26.67 | $10.30 |
| Resistance Level | $31.71 | $10.39 |
| Average True Range (ATR) | 3.16 | 0.02 |
| MACD | -0.26 | -0.00 |
| Stochastic Oscillator | 20.92 | 77.78 |
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Rice Acquisition Corp 3 is a blank check company.